Skip to main navigation Skip to search Skip to main content

Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial

  • University of Ulsan
  • Sungkyunkwan University
  • Lunit, Inc.

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science